Advice on Epidyolex

Letter to the Home Office regarding the appropriate Schedule for the cannabis-based product for medicinal use, Epidyolex, under the Misuse of Drugs Regulations 2001.


Advice on Epidyolex

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email Please tell us what format you need. It will help us if you say what assistive technology you use.


The ACMD Chair, Professor Owen Bowden-Jones, and the ACMD’s Technical Committee Chair, Professor Roger Knaggs, write to the Minister of State for Crime, Policing and the Fire Service. They recommend that it would be most appropriate for Epidyolex, a cannabis-based product for medicinal use (CBPM), to be placed in Schedule 5 under the Misuse of Drugs Regulations 2001.

Published 29 January 2020